ANI
25 Jan 2023, 21:18 GMT+10
By Shalini BhardwajNew Delhi [India], January 25 (ANI): A day after the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine for the prevention of cervical cancer, Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday said that the availability of the vaccine will be little in number this year, however, it would be boosted next year.
Poonawalla briefed Union Health Minister Mansukh Mandaviya about the HPV vaccine in the national capital.
Speaking to ANI after the meeting, the SII CEO said, "I had come to brief the Union Health minister about it. We'll wait for the government program to roll out. Capacity is very small this year but we'll build a large capacity to take care of the entire nation's needs for next year."Talking about the rollout programme of the vaccine, Poonawalla said that it would be done through government programmes this year.
"We will slowly roll it out through government programs this year. I can't comment on pricing now. We will wait for tendering process and follow government protocols," he said.
On Tuesday Serum Institute of India launched first made-in-India HPV vaccine for cervical cancer.
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, announced the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer.
The launch took place in the presence of Home Minister Amit Shah, Adar Poonawalla, and the Director of GovernmentRegulatory Affairs at Serum Institute of India, Prakash K Singh.
"On the occasion of India's National Girl Child Day and Cervical Cancer Awareness Month, @SerumInstIndia is pleased to launch the first made-in-India HPV vaccine by the hands of our Hon'ble Home Minister Shri @AmitShah Ji. @PrakashKsingh7," tweeted Adar Poonawalla.
'CERVAVAC' is an outcome of a partnership of DBT and BIRAC with the Bill and Melinda Gates Foundation, supported by Serum Institute of India Private Limited for the indigenous development of quadrivalent vaccine through its partnership programme 'Grand Challenges India'. (ANI)
Get a daily dose of New York Statesman news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to New York Statesman.
More InformationIt's been 20 years since the Secretary of State made his UN Security Council address, fake anthrax vial in hand, ...
Children look at books at the Border Line Crisis Center shelter in Tijuana, Mexico. ...
Mourners arrive to the funeral service for Tyre Nichols, at Mississippi Boulevard Christian Church on Wednesday, Feb. 1, 2023, in ...
The ruling allows advancement of solar in the only way it can be advanced. ...
Pulaski Academy coach Kevin Kelley, center, celebrates with his team after the Arkansas Class 5A High School Championship football game ...
Thank you notes made by migrant children who stay at the San Diego Rapid Response Network Migrant Shelter Services in ...
WASHINGTON D.C.: The Biden administration has indicated that it could end federal protection for grizzly bears in the northern Rocky ...
MANILA, Philippines: The Philippines has granted the United States four more locations to open military bases, U.S. Defense Secretary Lloyd ...
WASHINGTON, DC - The global community has extended aid to Turkey and Syria following the devastating earthquakes that hit the ...
WASHINGTON D.C.: US lawmakers have called on the Department of Energy to release documents detailing attempts by Russian hackers to ...
Photo credit: Ercin Erturk / Anadolu AgencyThe death toll from Monday's massive 7.8 magnitude earthquake in Turkey and Syria has ...
WASHINGTON D.C.: In a sign of future political battles over record numbers of illegal crossings under Democratic President Joe Biden, ...